Skip to content
DraconiticResearch
Search Sources API
206,690 studies31 sourcesUpdated 48 min ago

Oncology

5,185 studies511 in 7 days2,486 in 30 days

Filters
Type
Date
Clear

Latest

5,185 studies

  1. PSAT1 integrates ferroptosis resistance and immune evasion to drive hepatocellular carcinoma progression
    Chi Zhang, Yue Yang, Wei Tian +6
    Science AdvancesPeer-reviewedCC BYFull textOncologySci. Adv.CrossrefEurope PMCPMC
  2. Comparing the efficacy and safety of raltitrexed combined with irinotecan administered in different dose-schedule patterns for the second-line treatment of metastatic colorectal cancer: an exploratory, observational post hoc analysis from the prospective SALLY registry cohort.
    Nuoya Yu, Ziyan Tong, Yaohua Fan +4
    Journal of gastrointestinal oncologyPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
  3. Prospective evaluation of indocyanine green fluorescence for anastomotic site selection in laparoscopic colorectal cancer surgery
    Antonio Rocco Imperiale, Lucas Faraco Sobrado, Carlos Frederico Sparapan Marques +4
    ClinicsPeer-reviewedCC BY 4.0Full textOncologyPMC
  4. Emerging role of non-coding RNAs in the progression of MASLD-driven hepatocellular carcinoma (Review)
    Weihua Zheng, Caiyan An, Long Xia +3
    International Journal of Molecular MedicinePeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  5. Disrupting the cholesterol–mechanics axis enables ferroptosis and deep drug delivery in hepatocellular carcinoma
    Jinying Zhu, Yangping Zhong, Shuangqian Yan +1
    Bioactive MaterialsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  6. Three-dimensional culture suppresses pancreatic fibroblast activation and limits paracrine signaling between pancreatic cancer cells and fibroblasts
    Nino Javakhishvili, Anais Zourelidis, Bogusz Trojanowicz +2
    Biochemistry and Biophysics ReportsPeer-reviewedCC BY 4.0Full textOncologyPMC
  7. First-in-human quad-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trial
    Rebecca Ronsley, Marlena Bannick, Prabha Narayanaswamy +43
    Research SquarePreprintCC BY 4.0Full textOncologyPMC
  8. Targeting G2/M checkpoint vulnerability in homologous recombination-proficient tumors: lessons from ovarian cancer models
    Qian Xi, Akiko Kunita, Saeko Nagai +3
    Cell CyclePeer-reviewedCC BY 4.0Full textOncologyPMC
  9. Longitudinal psychosocial burden, quality of life, and digital supportive care preferences before and after CAR T-cell therapy: a prospective single-center observational study
    Anna Fleischer, Sabine-Anna Bergert, Patrick-Pascal Strunz +12
    BMC CancerPeer-reviewedCC BY 4.0Full textOncologyPMC
  10. Intratumoral Klebsiella pneumoniae drives metabolic-immune remodeling and immunotherapy resistance in bladder cancer
    Ruilin Zhuang, Zhiming Wu, Runhao Zheng +10
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  11. Non-canonical function of SCIMP restricts JAK1 activity to counteract immune evasion in bladder cancer
    Yongqiang You, Hui Zhang, Jiayin Sun +9
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  12. Early Assessment of Circulating Tumor Cells and Their PD-L1 Expression as Predictive Biomarkers in Metastatic Non-Small Cell Lung Cancer Patients Treated with Immunotherapy: An Exploratory Study
    Emmanuel Grolleau, David Barthelemy, Aurélien Millet +10
    ImmunoTargets and TherapyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  13. Unraveling the EMT Spectrum in Aggressive Breast Cancer: Bridging Molecular Hybrid States with Functional Assay Interpretation
    Nurul Utami, Karina Fitria Alhaq, Nandina Oktavia +3
    OncoTargets and TherapyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  14. Circulating Biomarkers with Artificial Intelligence for Clinical Risk Assessment and Therapeutic Monitoring: Evidence, Limitations, and Translation
    Wenyuan Wei, Rui Zhang, Zhiying Zhang
    Therapeutics and Clinical Risk ManagementPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  15. Genome Sequencing Outperforms Exome Sequencing in Formalin‐Fixed Paraffin Embedded Tumors Leading to Improved Treatment Options
    Nadja Ballin, Alexander Ott, Michaela Pogoda +15
    Cancer MedicinePeer-reviewedCC BY 4.0Full textOncologyPMC
  16. Uncovering KRAS-mutant allele-specific biology and vulnerabilities in non-small cell lung cancer
    Paolo D. d'Arienzo, William J. McDaid, Kirsten L. Tinsley +4
    Biochemical JournalPeer-reviewedCC BY 4.0Full textOncologyPMC
  17. Breaking the Silence: A Mixed Methods Analysis Unveiling Barriers to Mental Health Service Use in Breast Cancer Survivors With Clinically Significant Distress
    Ana Danner, Tayler Gowan, Madison Schwarz +3
    Psycho-OncologyPeer-reviewedCC BY 4.0Full textOncologyPMC
  18. Associations of Cancer Rehabilitation During Hospitalization for Cancer Treatment With Survival and Post–Discharge Healthcare Utilization: A Multicenter Retrospective Cohort Study
    Toshitaka Morishima, Yoshihiro Kuwabara, Mizuki Shimadzu Kato +6
    Cancer MedicinePeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  19. Three-week ileostomy closure after colorectal surgery: a multicenter randomized trial of technical and postoperative outcomes
    Y. Debakey, M. S. Mostafa, A. Kilany +7
    Techniques in ColoproctologyPeer-reviewedCC BY-NC-ND 4.0Full textOncologyPMC
  20. Deep Learning-Based Classification of Melanoma Using Dermoscopic Images: Comparative Evaluation of Convolutional Neural Network and DenseNet Models.
    Harshal Sanghvi, Argyrios Agritis, Isabella Alvarez +5
    JMIR dermatologyPeer-reviewedCC BYFull textOncologyEurope PMCPMC
  21. Autophagy and intratumoral bacteria abundance influence the prognosis of patients with pancreatic carcinoma.
    Yifan Zhang, Toohina L Gobin, Zhenhua Huang +17
    Cell death & diseasePeer-reviewedCC BYFull textOncologyEurope PMCPMC
  22. Robotic versus open pancreatoduodenectomy in patients with obesity: propensity score-matched multicentre study
    Valentina Valle, Tiziana Marchese, Benedetto Ielpo +77
    BJS OpenPeer-reviewedCC BY 4.0Full textOncologyPMC
  23. Prognostic Value of LINC01140 in Colorectal Cancer and Its Regulatory Effect on Chemotherapy Resistance via miR‐942‐5p/NRXN1
    Jian Zhao, Songjie Liu, Bing Xu
    Journal of Biochemical and Molecular ToxicologyPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  24. An Australian Narrative Review of Adoptive Cellular Therapies in Malignancy: Expanding Indications, Referral Pathways and Safety Beyond Specialist Centres
    Sarah Childs, David Ma, Anthony Rodrigues +13
    The Medical Journal of AustraliaPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  25. “No… Nobody told me anything about that”: a qualitative study on pretreatment knowledge of individuals with lung or head and neck cancer regarding the disease, treatments, and physical exercise
    Isabela Duarte, Karina Arielle da Silva Souza, Alice Haniuda Moliterno +4
    Supportive Care in CancerPeer-reviewedCC BY 4.0Full textOncologyPMC